Mirae Asset Global ETFs Holdings’s Edgewise Therapeutics EWTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	32,939 +1,325	+4%	+$45.7K	﹤0.01%	1478
2026 Q1	$996K	Buy	31,614 +245	+0.8%	+$7.07K	﹤0.01%	1527
2025 Q4	$778K	Buy	31,369 +19	+0.1%	+$381	﹤0.01%	1663
2025 Q3	$508K	Sell	31,350 -8,628	-22%	-$122K	﹤0.01%	1864
2025 Q2	$524K	Sell	39,978 -3,798	-9%	-$54.8K	﹤0.01%	1798
2025 Q1	$963K	Buy	43,776 +2,463	+6%	+$64.6K	﹤0.01%	1520
2024 Q4	$1.1M	Buy	41,313 +1,595	+4%	+$50.8K	﹤0.01%	1495
2024 Q3	$1.06M	Buy	39,718 +10,432	+36%	+$208K	﹤0.01%	1513
2024 Q2	$527K	Buy	+29,286	New	+$511K	﹤0.01%	1801

Other funds holding EWTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's EWTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Edgewise Therapeutics (EWTX) stake by 4.2% in Q2 2026, buying an estimated $45.7K and bringing the position to 32,939 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Mirae Asset Global ETFs Holdings first reported a position in EWTX in Q2 2024 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 32,939 shares of Edgewise Therapeutics worth $1.34M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,325 Edgewise Therapeutics shares in Q2 2026, an estimated $45.7K.
Edgewise Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1478 holding.
Mirae Asset Global ETFs Holdings first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 9 quarters since.
226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.